Willingness to pay for AIDS treatment: Myths and realities

Lancet

Volumn 362, Issue 9390, 2003, Pages 1152-1153

  Binswanger, Hans P ^a  

^a WORLD BANK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; GENERIC DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COST EFFECTIVENESS ANALYSIS; DEATH; DISEASE COURSE; HEALTH CARE COST; HEALTH INSURANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; PILOT STUDY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY; TREATMENT OUTCOME;

EID: 0141863186     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14473-X     Document Type: Note

References (14)

1. UNAIDS. Report on the Global AIDS Epidemic, Barcelona, July 2002. http://www.unaids.org (accessed Nov 1, 2002).
2. WHO. Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach, June 2002. http://www.who.int/HIV_AIDS/CARE/ScalingUp_Guidelines_Final021002.pdf (accessed Nov 1, 2002).
3. Simon J., Rosen S., Whiteside A., Vincent J., Thea D. The response of African businesses to HIV/IADS. HIV/AIDS in the Commonwealth 2000/01. 2000;4 Kensington Publications, London.
4. Rosen S, Simon J, Jeffrey R, et al. AIDS is Your Business. Harvard Business Review, February, 2003. 80-87.
5. Binswanger H, Israelski D, Jere G, Sall A, Vaurs R. The association-driven care and treatment model for HIV/AIDS. Paper presented at the XIV Congress on AIDS in Barcelona, July 7-12, 2002. http://www.aidseti.org.ABTM.pdf (accessed April 24, 2003).
6. Rivers B. Filling the funding gap to save lives: a proposal for an equitable contributions framework for the Global Fund. http://www.globalaidsalliance.org/Filling_the_Funding_Gap_09Oct02.pdf . (accessed April 24, 2003).
7. Do M, Berman D. XIVth International HIV/AIDS Conference 2002: background information on HIV/AIDS. http://www.accessmed-msf.org/prod/publications.asp?scntid=15520021210393& contenttype=PARA& (accessed Nov 1, 2002).
8. Marseille E., Hofman P.B., Kahn J. HIV prevention before HAART in sub-Saharan Africa. Lancet. 359:2002;1851-1856.
9. Donnelly J. Prevention urged in AIDS fight. Boston Globe (Boston). June 7, 2001: 8.
10. Weidle P., Malamba S., Mwebaze R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet. 360:2002;34-40.
11. Desclaux A., Laniece I., Ndoye I., Taverne B. L'Initiative Senegalaise d'Acces aux Medicaments Retroviraux. 2001;ANRS, Editions EDK, Paris.
12. Msellati P., Vidal L., Moatti J.P. L'acces aux traitements du VIH/Sida en Cote d'Ivoire. 2002;ANRS, Editions EDK, Paris.
13. UNAIDS. Fact sheet: the impact of HIV/AIDS. http://www.unaids.org/barcelona/presskit/factsheets/FSimpact_en.pdf (accessed Nov 1, 2002).
14. Binswanger H. AIDS treatment for millions. Science. 292:2001;221-223.